Peer-influenced content. Sources you trust. No registration required. This is HCN.
Dana-Farber Cancer Institute
Patients receiving pembrolizumab before, during, and after surgery demonstrated longer event-free survival and higher substantial tumor shrinkage rates, with median survival extending from 30.4 to 51.8 months compared to standard care alone.
Oncology, Medical July 22nd 2025
Cleveland Clinic Journal of Medicine (CCJM)
Recent case findings underscore the pivotal role of oral hygiene in preventing benign gingival masses. A patient’s neglect during hospital stay led to a fibroma, spotlighting the need for heightened oral care in clinical settings.
Dentistry January 24th 2024
Decisions in Dentistry
Check out Decisions in Dentistry’s latest course on MRONJ. Uncover new insights and enhance your dental practice.
Dentistry October 17th 2023
Journal of the American Dental Assocation (JADA)
Discover how new guidelines from the American Academy of Oral and Maxillofacial Radiology are set to change long-standing practices in radiation shielding during dentomaxillofacial imaging. Learn more about what this means for your practice and patient safety.
Dentistry September 18th 2023
British Dental Journal (BDJ)
Discover how a unique case of necrotising sialometaplasia and pericoronitis challenges conventional diagnostic approaches and underscores the importance of comprehensive testing. Learn more to enhance your diagnostic acumen.